Unrealistic expectations plague U.K. IT program

Article

National Health Service workers in the U.K. are disappointed with the suboptimal rollout of the country's national program for information technology, according to a survey published in the August issue of the British Medical Journal.

National Health Service workers in the U.K. are disappointed with the suboptimal rollout of the country's national program for information technology, according to a survey published in the August issue of the British Medical Journal.

Respondents to a survey of four hospitals reported a lack of clarity and communication from the national IT program's headquarters regarding future program developments. Unrealistic timelines and uncertain IT implementation schedules resulted in low morale in the NHS staff involved in IT implementation, the report said.

Even the promise of short-term benefits could not persuade NHS staff to embrace the national program enthusiastically, especially if they lost local IT functionality during the transition to a national IT infrastructure.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.